Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Human TLR4 Reporter HEK293 Cells (NF-κB) Surface immunogenic protein from Streptococcus agalactiae and Fissurella lati... 2023 Front Immunol. Díaz-Dinamarca D.A. et al. DOI: 10.3389/fimmu.2023.1186188
HEK-Blue™ Detection Surface immunogenic protein from Streptococcus agalactiae and Fissurella lati... 2023 Front Immunol. Díaz-Dinamarca D.A. et al. DOI: 10.3389/fimmu.2023.1186188
TRIF KO Dual Reporter THP1 Cells Surface immunogenic protein from Streptococcus agalactiae and Fissurella lati... 2023 Front Immunol. Díaz-Dinamarca D.A. et al. DOI: 10.3389/fimmu.2023.1186188
pFUSE-CHIg-hG1 Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing si... 2023 Commun Biol. Akiba H. et al. DOI: 10.1038/s42003-023-05326-8
pFUSE2-CLIg-hK Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing si... 2023 Commun Biol. Akiba H. et al. DOI: 10.1038/s42003-023-05326-8
Ramos-Blue™ Cells Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing si... 2023 Commun Biol. Akiba H. et al. DOI: 10.1038/s42003-023-05326-8
PlasmoTest™ - Mycoplasma Detection Kit DNA2 nuclease inhibition confers synthetic lethality in cancers with mutant p... 2023 Cancer Res Commun. Folly-Kossi H. et al. DOI: 10.1158/2767-9764.CRC-23-0166
Puromycin Nifuroxazide boosts the anticancer efficacy of induced senescence by dual inh... 2023 Cell Death Discov. Wang X. et al. DOI: 10.1038/s41420-023-01658-w
Puromycin Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and i... 2023 J Biol Chem. Burghi V. et al. DOI: 10.1016/j.jbc.2023.105293
MycoStrip™ - Mycoplasma Detection Kit FGFR3 alterations in bladder cancer stimulate serine synthesis to induce immu... 2023 Cancer Res. Ouyang Y. et al. DOI: 10.1158/0008-5472.CAN-23-1065
Primocin® Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negat... 2023 Breast Cancer Res. Luo D. et al. DOI: 10.1186/s13058-023-01709-1
MycoStrip™ - Mycoplasma Detection Kit ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transitio... 2023 Neoplasia Katoh I. et al. DOI: 10.1016/j.neo.2023.100938
RAW-Lucia™ ISG Cells Tumor-Myeloid Cell Crosstalk Pathways Associated with Abscopal Responses in B... 2023 Int J Radiat Oncol Biol Phys. Goddard A. et al. DOI: 10.1016/j.ijrobp.2023.06.1150
THP1-Null2 Cells Understanding How Cationic Polymers' Properties Inform Toxic or Immunogenic R... 2023 Macromolecules Weiss A.M. et al. DOI: 10.1021/acs.macromol.3c01223
LPS-EB (LPS from E. coli O111:B4) Understanding How Cationic Polymers' Properties Inform Toxic or Immunogenic R... 2023 Macromolecules Weiss A.M. et al. DOI: 10.1021/acs.macromol.3c01223
NLRP3 KO & KD THP-1 Cells Understanding How Cationic Polymers' Properties Inform Toxic or Immunogenic R... 2023 Macromolecules Weiss A.M. et al. DOI: 10.1021/acs.macromol.3c01223
ASC-GFP Reporter Monocytes Understanding How Cationic Polymers' Properties Inform Toxic or Immunogenic R... 2023 Macromolecules Weiss A.M. et al. DOI: 10.1021/acs.macromol.3c01223
Primocin® Pharmacological inhibition of bromodomain and extra-terminal proteins induces... 2023 PLoS Pathog. Mhlekude B. et al. DOI: 10.1371/journal.ppat.1011657
Ruxolitinib Pharmacological inhibition of bromodomain and extra-terminal proteins induces... 2023 PLoS Pathog. Mhlekude B. et al. DOI: 10.1371/journal.ppat.1011657
Puromycin Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer m... 2023 Acta Pharmacol Sin. Liu H. et al. DOI: 10.1038/s41401-023-01158-8

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty